Prevalence of ERα-397 PvuII C/T, ERα-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women

Polymorphisms of hormone receptor genes have been linked to modifications in reproductive factors and to an increased risk of breast cancer (BC). In the present study, we have determined the allelic and genotypic frequencies of the ERα-397 PvuII C/T, ERα-351 XbaI A/G and PGR PROGIN...

Full description

Bibliographic Details
Main Authors: J. Giacomazzi, E. Aguiar, E.I. Palmero, A.V. Schmidt, G. Skonieski, D.D. Filho, H. Bock, M.L. Saraiva-Pereira, I.P. Ewald, L. Schuler-Faccini, S.A. Camey, M. Caleffi, R. Giugliani, P. Ashton-Prolla
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2012-10-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012001000002
_version_ 1818023214582857728
author J. Giacomazzi
E. Aguiar
E.I. Palmero
A.V. Schmidt
G. Skonieski
D.D. Filho
H. Bock
M.L. Saraiva-Pereira
I.P. Ewald
L. Schuler-Faccini
S.A. Camey
M. Caleffi
R. Giugliani
P. Ashton-Prolla
author_facet J. Giacomazzi
E. Aguiar
E.I. Palmero
A.V. Schmidt
G. Skonieski
D.D. Filho
H. Bock
M.L. Saraiva-Pereira
I.P. Ewald
L. Schuler-Faccini
S.A. Camey
M. Caleffi
R. Giugliani
P. Ashton-Prolla
author_sort J. Giacomazzi
collection DOAJ
description Polymorphisms of hormone receptor genes have been linked to modifications in reproductive factors and to an increased risk of breast cancer (BC). In the present study, we have determined the allelic and genotypic frequencies of the ER&#945;-397 PvuII C/T, ER&#945;-351 XbaI A/G and PGR PROGINS polymorphisms and investigated their relationship with mammographic density, body mass index (BMI) and other risk factors for BC. A consecutive and unselected sample of 750 Brazilian BC-unaffected women enrolled in a mammography screening program was recruited. The distribution of PGR PROGINS genotypic frequencies was 72.5, 25.5 and 2.0% for A1A1, A1A2 and A2A2, respectively, which was equivalent to that encountered in other studies with healthy women. The distribution of ER&#945; genotypes was: ER&#945;-397 PvuII C/T: 32.3% TT, 47.5% TC, and 20.2% CC; ER&#945;-351 XbaI A/G: 46.3% AA, 41.7% AG and 12.0% GG. ER&#945; haplotypes were 53.5% PX, 14.3% Px, 0.3% pX, and 32.0% px. These were significantly different from most previously published reports worldwide (P < 0.05). Overall, the PGR PROGINS genotypes A2A2 and A1A2 were associated with fatty and moderately fatty breast tissue. The same genotypes were also associated with a high BMI in postmenopausal women. In addition, the ER&#945;-351 XbaI GG genotype was associated with menarche &#8805;12 years (P = 0.02). ER&#945; and PGR polymorphisms have a phenotypic effect and may play an important role in BC risk determination. Finally, if confirmed in BC patients, these associations could have important implications for mammographic screening and strategies and may be helpful to identify women at higher risk for the disease.
first_indexed 2024-12-10T03:40:46Z
format Article
id doaj.art-50c548e3c7d04fe3873db8f3da05cc65
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-12-10T03:40:46Z
publishDate 2012-10-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-50c548e3c7d04fe3873db8f3da05cc652022-12-22T02:03:34ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2012-10-014510891897Prevalence of ER&#945;-397 PvuII C/T, ER&#945;-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected womenJ. GiacomazziE. AguiarE.I. PalmeroA.V. SchmidtG. SkonieskiD.D. FilhoH. BockM.L. Saraiva-PereiraI.P. EwaldL. Schuler-FacciniS.A. CameyM. CaleffiR. GiuglianiP. Ashton-ProllaPolymorphisms of hormone receptor genes have been linked to modifications in reproductive factors and to an increased risk of breast cancer (BC). In the present study, we have determined the allelic and genotypic frequencies of the ER&#945;-397 PvuII C/T, ER&#945;-351 XbaI A/G and PGR PROGINS polymorphisms and investigated their relationship with mammographic density, body mass index (BMI) and other risk factors for BC. A consecutive and unselected sample of 750 Brazilian BC-unaffected women enrolled in a mammography screening program was recruited. The distribution of PGR PROGINS genotypic frequencies was 72.5, 25.5 and 2.0% for A1A1, A1A2 and A2A2, respectively, which was equivalent to that encountered in other studies with healthy women. The distribution of ER&#945; genotypes was: ER&#945;-397 PvuII C/T: 32.3% TT, 47.5% TC, and 20.2% CC; ER&#945;-351 XbaI A/G: 46.3% AA, 41.7% AG and 12.0% GG. ER&#945; haplotypes were 53.5% PX, 14.3% Px, 0.3% pX, and 32.0% px. These were significantly different from most previously published reports worldwide (P < 0.05). Overall, the PGR PROGINS genotypes A2A2 and A1A2 were associated with fatty and moderately fatty breast tissue. The same genotypes were also associated with a high BMI in postmenopausal women. In addition, the ER&#945;-351 XbaI GG genotype was associated with menarche &#8805;12 years (P = 0.02). ER&#945; and PGR polymorphisms have a phenotypic effect and may play an important role in BC risk determination. Finally, if confirmed in BC patients, these associations could have important implications for mammographic screening and strategies and may be helpful to identify women at higher risk for the disease.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012001000002Genetic polymorphismsEstrogen receptor geneProgesterone receptor geneBreast cancer susceptibility
spellingShingle J. Giacomazzi
E. Aguiar
E.I. Palmero
A.V. Schmidt
G. Skonieski
D.D. Filho
H. Bock
M.L. Saraiva-Pereira
I.P. Ewald
L. Schuler-Faccini
S.A. Camey
M. Caleffi
R. Giugliani
P. Ashton-Prolla
Prevalence of ER&#945;-397 PvuII C/T, ER&#945;-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women
Brazilian Journal of Medical and Biological Research
Genetic polymorphisms
Estrogen receptor gene
Progesterone receptor gene
Breast cancer susceptibility
title Prevalence of ER&#945;-397 PvuII C/T, ER&#945;-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women
title_full Prevalence of ER&#945;-397 PvuII C/T, ER&#945;-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women
title_fullStr Prevalence of ER&#945;-397 PvuII C/T, ER&#945;-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women
title_full_unstemmed Prevalence of ER&#945;-397 PvuII C/T, ER&#945;-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women
title_short Prevalence of ER&#945;-397 PvuII C/T, ER&#945;-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women
title_sort prevalence of er 945 397 pvuii c t er 945 351 xbai a g and pgr progins polymorphisms in brazilian breast cancer unaffected women
topic Genetic polymorphisms
Estrogen receptor gene
Progesterone receptor gene
Breast cancer susceptibility
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012001000002
work_keys_str_mv AT jgiacomazzi prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT eaguiar prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT eipalmero prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT avschmidt prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT gskonieski prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT ddfilho prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT hbock prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT mlsaraivapereira prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT ipewald prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT lschulerfaccini prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT sacamey prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT mcaleffi prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT rgiugliani prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen
AT pashtonprolla prevalenceofer945397pvuiicter945351xbaiagandpgrproginspolymorphismsinbrazilianbreastcancerunaffectedwomen